Form 4: Cidara Therapeutics CEO Acquires 1,040,000 Stock Options

Sentiment:

SEC Form 4 Filing


Cidara Therapeutics' CEO, Jeffrey Stein, acquired 1,040,000 stock options on March 15, 2024, exercisable at $0.6849 per share.

Summary

  • On March 15, 2024, Jeffrey Stein, the President & CEO and a Director of Cidara Therapeutics, Inc., filed a Form 4 indicating changes in his beneficial ownership of the company's securities.
  • Stein acquired 1,040,000 employee stock options with an exercise price of $0.6849.
  • These options vest in 36 equal monthly installments starting March 15, 2024, and expire on March 14, 2034.
  • Stein directly owns 1,153,693 shares of common stock.
  • He also indirectly owns 331,602 shares through a trust and 42,009 shares through his son.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The acquisition of options could be seen as a positive sign of the CEO's confidence, but it's a routine event.

Positives

  • The acquisition of stock options by the CEO could align his interests with those of the shareholders, incentivizing him to improve the company's performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the CEO's holdings of Cidara Therapeutics securities.

Stakeholder Impact

  • The acquisition of stock options by the CEO could potentially impact shareholder value if it incentivizes him to improve company performance.

Key Dates

DateDescription
03/15/2024Date of earliest transaction (acquisition of stock options) and Vesting Commencement Date.
03/20/2024Date of Form 4 filing.
03/14/2034Expiration date of the acquired stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.